Impact Biomedical (IBO) Shares Outstanding (2022 - 2026)

Impact Biomedical (IBO) has 5 years of Shares Outstanding (Entity) data on file, last reported at $107.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 793.84% year-over-year to $107.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.8 million (up 793.84% YoY) and the FY2025 annual result came in at $31.6 million, up 193.3% from the prior year.
• Shares Outstanding (Entity) grew to $107.8 million in Q1 2026, from $31.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $107.8 million in Q1 2026 to a low of $10.0 million in Q2 2024.
• A 5-year average of $46.9 million and a median of $60.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) tumbled 85.82% — and 2026, when it jumped 793.84%.
• Tracing IBO's Shares Outstanding (Entity) over 5 years: stood at $70.5 million in 2022, then slipped by 14.18% to $60.5 million in 2023, then sank by 82.22% to $10.8 million in 2024, then jumped by 193.3% to $31.6 million in 2025, then jumped by 241.74% to $107.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $107.8 million (Q1 2026), $31.6 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.